InBody Co

InBody Co Financial Leverage

The Financial Leverage (Equity Multiplier) of InBody Co (041830.KQ) as of Oct 25, 2026 is 1.14. In the previous year, Financial Leverage (Equity Multiplier) was 1.12 — a change of 1.39% (higher).

Financial Leverage

1.14

YoY

1.39%

Last updated:

Financial Leverage (Equity Multiplier) of InBody Co is 2025 1.14 . Financial Leverage (Equity Multiplier) of InBody Co was 2024 1.12 . It decreases by 1.39% higher compared to the previous year.

The InBody Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.06 KRW
Jan 1, 2019
1.11 KRW
Jan 1, 2020
1.11 KRW
Jan 1, 2021
1.11 KRW
Jan 1, 2022
1.13 KRW
Jan 1, 2023
1.10 KRW
Jan 1, 2024
1.12 KRW
Jan 1, 2025
1.14 KRW
The InBody Co Financial Leverage history
YEARFinancial LeverageYoY
1.14+1.39%
1.12+1.55%
1.10-2.13%
1.13+1.65%
1.11+0.16%
1.11-0.15%
1.11+4.74%
1.06+0.63%
1.05+0.05%
1.05-2.76%
1.08+2.00%
1.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

Financial Leverage (Equity Multiplier) of InBody Co is 1.14 in 2025.

Financial Leverage (Equity Multiplier) of InBody Co changed from 1.12 to 1.14, representing a 1.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) InBody Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s InBody Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — InBody Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — InBody Co